Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study

BACKGROUND: There is increasing evidence that combination therapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) and programmed cell death protein 1 (PD-1) inhibitor is safe and efficacious in treating many types of malignant tumors. However, clinical data demonstrating the effect of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Zhichao, Dong, Shuping, Yang, Yang, Gao, Shilei, Yang, Yonghao, Yang, Jinpo, Zhang, Peng, Wang, Xin, Yao, Weitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756702/
https://www.ncbi.nlm.nih.gov/pubmed/35022029
http://dx.doi.org/10.1186/s12885-022-09176-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756702/
https://www.ncbi.nlm.nih.gov/pubmed/35022029
http://dx.doi.org/10.1186/s12885-022-09176-1

Ejemplares similares